Involvement of Platelet Activation by P2Y12 Receptor in the Development of Transplant Arteriosclerosis in Mice

被引:17
|
作者
Yashiro, Kenichi
Matsumoto, Yuji
Ihara, Hayato [2 ]
Suzuki, Yasuhiro
Kondo, Kazunao
Urano, Tetsumei [2 ]
Umemura, Kazuo [1 ]
机构
[1] Hamamatsu Univ Sch Med, Dept Pharmacol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan
关键词
Platelet; P2Y(12) receptor; Carotid transplantation; Vasculopathy; Inflammation; CARDIAC ALLOGRAFTS; CAROTID ALLOGRAFTS; CYCLOSPORINE-A; ADP RECEPTOR; MOUSE MODEL; P-SELECTIN; EXPRESSION; CELLS; INFLAMMATION; DYNAMICS;
D O I
10.1097/TP.0b013e318196305a
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Although activated platelets influence inflammation by intraplatelet mediators in transplantation, their mechanism of involvement in the progression of transplant arteriosclerosis has not yet been elucidated. We, therefore, investigated this question using P2Y(12) receptor knockout (KO) mice, in which platelets cannot be aggregated by adenosine diphosphate stimulation. Methods. Carotid arteries from 129XI mice were orthotopically transplanted into wild-type or KO mice in a minor antigen(s)-mismatched strain combination. No immunosuppression was used. Grafts were harvested at 7, 14, 28, and 56 days after transplantation for morphometry and immunohistology. Fluorescence-activated cell sorting and quantitative real-time reverse-transcriptase polymerase chain reaction were performed at 7 and 14 days after transplantation. Results. The intima/media ratio of grafts in KO mice was significantly reduced compared with wild-type mice at 14,28, and 56 days after transplantation. Fluorescence-activated cell sorting analysis showed a significant reduction of platelet CD 154 expression and platelet-leukocyte aggregates in KO mice at 14 days after transplantation. Additionally, levels of intercellular adhesion molecule-1 and CD40 mRNA, and numbers of intercellular adhesion molecule-1- or CD40-positive cells in the grafts were lower in KO mice at 7 and 14 days after transplantation. These reductions resulted in a significant attenuation of CD45-positive leukocytes adhering to the graft vessel wall in KO mice at 14 days after transplantation. Conclusion. Diminished platelet function by P2Y(12) receptor deficiency attenuates initiation and strongly inhibits progression of transplant arteriosclerosis in mice by diminishing adhesion molecule expression and leukocyte accumulation in the grafts during the early phase after transplantation.
引用
收藏
页码:660 / 667
页数:8
相关论文
共 50 条
  • [21] A critical role for the ADP receptor, P2Y12, in Streptococcus oralis induced platelet activation
    Tilley, D. O.
    Maume, S. A.
    Cox, D.
    Smolenski, A.
    Douglas, C. W., I
    Kerrigan, S. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 776 - 776
  • [22] The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor
    Bouman, Heleen J.
    van Werkum, Jochem W.
    Rudez, Goran
    Leebeek, Frank W. G.
    Kruit, Adrian
    Hackeng, Christian M.
    ten Berg, Jurrien M.
    de Maat, Moniek P. M.
    Ruven, Henk J. T.
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (02) : 379 - 386
  • [23] Involvement of Cys194 in the interaction of the human platelet P2Y12 receptor with reactive blue 2
    Hoffmann, Kristina
    Lutz, Dominique
    Baqi, Younis
    Mueller, Christa E.
    von Kuegelgen, Ivar
    PURINERGIC SIGNALLING, 2012, 8 (01) : 151 - 152
  • [24] Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist
    Wilson, William
    Gurvitch, Ronen
    Ajani, Andrew E.
    CARDIOVASCULAR THERAPEUTICS, 2009, 27 (03) : 194 - 198
  • [25] Role of P2Y12 receptor at formation of heterogeneous platelet subpopulations
    Kotova, Y.
    Panteleev, M. A.
    Ataullakhanov, F.
    FEBS JOURNAL, 2008, 275 : 325 - 325
  • [26] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2009, 28 (04) : 513 - 514
  • [27] Pharmacogenetics and safety parameters for platelet P2Y12 receptor antagonists
    Richard C. Becker
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 513 - 514
  • [28] Decreased platelet inhibition by P2Y12 receptor blockers in anaemia
    Wadowski, Patricia P.
    Kopp, Christoph W.
    Koppensteiner, Renate
    Lang, Irene M.
    Pultar, Joseph
    Lee, Silvia
    Weikert, Constantin
    Panzer, Simon
    Gremmel, Thomas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (01)
  • [29] Platelet P2Y12 Receptor Inhibition and Perioperative Patient Management
    Mazzeffi, Michael
    Tanaka, Kenichi A.
    Gurbel, Paul A.
    Tantry, Udaya S.
    Levy, Jerrold H.
    ANESTHESIOLOGY, 2025, 142 (01) : 202 - 216
  • [30] Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors
    Adamski, Piotr
    Kozinski, Marek
    Ostrowska, Malgorzata
    Fabiszak, Tomasz
    Navarese, Eliano Pio
    Paciorek, Przemyslaw
    Grzesk, Grzegorz
    Kubica, Jacek
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (02) : 224 - 242